- Home
- WF vs BAX Comparison
WF vs BAX Comparison
Compare WF & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WF | BAX |
|---|---|---|
| Founded | 1899 | 1931 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 9.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WF | BAX |
|---|---|---|
| Price | $58.33 | $18.54 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 56.0K | ★ 8.3M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | ★ 3.68% | 0.22% |
| EPS Growth | ★ 20.51 | N/A |
| EPS | ★ 2.97 | N/A |
| Revenue | $8,054,512,650.00 | ★ $11,023,000,000.00 |
| Revenue This Year | N/A | $5.20 |
| Revenue Next Year | $4.26 | $2.02 |
| P/E Ratio | $6.47 | ★ N/A |
| Revenue Growth | ★ 23.56 | 3.90 |
| 52 Week Low | $29.44 | $17.40 |
| 52 Week High | $59.88 | $37.74 |
Technical Indicators
Market Signals| Indicator | WF | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 62.21 | 43.20 |
| Support Level | $57.48 | $18.33 |
| Resistance Level | $59.88 | $19.17 |
| Average True Range (ATR) | 1.39 | 0.54 |
| MACD | 0.50 | 0.21 |
| Stochastic Oscillator | 86.01 | 63.23 |
Price Performance
Historical ComparisonAbout WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.